🇫🇷 NFL Biosciences SAS

ALNFL.PA

Healthcare · France · EUR · nflbiosciences.com

Fundamentals

Gross Margin

-28.0%

Op. Margin

Net Margin

ROIC

Rev Growth

-100.0%

Valuation

Price

0.89 EUR

Day

-3.26%

52-Week Range

0.80 - 1.85

Market Cap

11M EUR

Fwd P/E

EV/EBITDA

Div Yield

Annual income statement #

NFL Biosciences SAS annual revenue, operating income and net income in EUR, 2020 to 2024. Revenue was 46 in 2024.

Year	Revenue (EUR)	Operating income	Net income
2024	46	-2.8m	-2.1m
2023	200,011	-4.4m	-3.7m
2021	39	-901,867	-978,244
2020	3	-318,028	-266,486

Financial Data #

Segment Breakdown #

Price & Multiples #

Peers #

Events #

Date	Type	Details	Price	Amount